The renewed strength in TAVR, following a slowdown last year tied to heart team capacity challenges at hospitals, prompted ...

Edwards TAVR segment reached $1.1bn in Q2 2025, up 8.9% compared to Q2 2024, while its heart valve segment increased by 61.9% ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights. Q2 sales g ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

EW's Q2 earnings report is likely to benefit from soaring TMTT sales, with the segment expected to jump over 57% year over ...

Edwards Lifesciences stock surged Friday after the medtech hiked its outlook following a key setback for rival Boston ...

Edwards Lifesciences reported Street-beating Q2 results, upping the lower end of its full-year sales guidance.

A Naples woman nearly lost her life to an aortic aneurysm during dance class - with almost no warning signs. Dr. Stapleton ...

In a surgical first, doctors have replaced a heart valve through a small neck incision using robotic assistance, avoiding the ...

However, this is the past; this article details the present and the near future. Several platforms have been evaluated in ...

An AI algorithm could help to predict which patients might develop significant heart problems years in advance, just based on ...